BenchSci Ranked Among Fastest-Growing Companies in North America on the 2025 Deloitte Technology Fast 500™

Toronto, CANADA, November 19, 2025 — BenchSci, a leading provider of AI software for biopharma research and development, today announced it ranked on the Deloitte Technology Fast 500™, a ranking of the 500 fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies in North America, now in its 31st year. BenchSci grew 247 per cent during this period.

“Our inclusion on the Fast 500 underscores the accelerating demand for technology that helps scientists navigate the complexities of disease biology with clarity, speed, and confidence,"  says Liran Belenzon, CEO & Co-Founder, BenchSci. “ASCEND is accelerating research at some of the world’s most influential pharmaceutical companies, and we’re deeply honored by the trust our partners place in our platform and our mission. Scientists face extraordinary challenges in getting biology right, and we are committed to equipping them with tools that meaningfully advance their work and accelerate breakthroughs."

“This year’s rankings highlight both enduring leadership and breakthrough momentum,” said Wolfe Tone, US Deloitte Private & Emerging Client Portfolio leader and partner, Deloitte Tax LLP. “More than half of the winners are prior honorees, yet the majority of the top ten are first-time entrants — demonstrating the staying power of established leaders alongside the accelerating growth of new innovators across key sectors. As in previous years, private companies continue to dominate, underscoring the agility that private enterprises bring to competitive markets, enabling the exceptional triple and quadruple digit growth reflected in these rankings.”

BenchSci previously ranked as a Technology Fast 50 and Fast 500 award winner in 2024. 

Overall, 2025 Technology Fast 500 companies achieved revenue growth ranging from 122% to 29,738% over the three-year time frame, with an average growth rate of 1,079%. 

About the 2025 Deloitte Technology Fast 500

Now in its 31st year, the Deloitte Technology Fast 500 provides a ranking of the fastest-growing technology, media, telecommunications, life sciences, fintech, and energy tech companies — both public and private — in North America. Technology Fast 500 award winners are selected based on percentage fiscal year revenue growth from 2021 to 2024.

In order to be eligible for Technology Fast 500 recognition, companies must own proprietary intellectual property or proprietary technology that significantly contributes to the company’s operating revenues. Companies must have base-year operating revenues of at least US$50,000, and current-year operating revenues of at least US$5 million, with a growth rate of 50% or greater. Additionally, companies must be in business for a minimum of four years and be headquartered within North America (United States and Canada).

About BenchSci

BenchSci is a world leader in AI software for biopharma research and development on a mission to exponentially increase the speed and quality of life-saving R&D to help bring new medicines to patients faster. We apply AI to understand how disease biology works throughout the drug discovery pipeline to solve the number one reason drug discovery projects fail—getting the biology wrong. Our platform, ASCEND, acts as a scalable AI assistant for preclinical organizations, increasing the productivity of the preclinical R&D pipeline across therapeutic areas. Backed by top-tier investors, including Generation Investment Management, iNovia Capital, TCV, F-Prime, Gradient Ventures (Google’s AI fund), and Golden Ventures, BenchSci has raised over $200 million. Our platform accelerates science at 16 top-20 pharmaceutical companies and over 4,500 leading research centers worldwide. For more information about BenchSci, visit www.benchsci.com.